相关实验视频

Updated: Feb 4, 2026

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

在不同年龄组的大型抑郁症中肥胖的代谢指数

Jieyu Zhou^1,2,3,4, Yukang Tan^1,2,3,4, Shasha Huang^1,2,3,4

¹Guangdong Provincial Hospital of Integrated Traditional Chinese and Western Medicine, Guangdong, People's Republic of China.

|February 3, 2026

概括

大型抑郁症 (MDD) 患者的肥胖风险随着年龄的增加而增加. 监测代谢指标,如BMI,年龄和特定的血液标记,对于及时的临床决策和降低肥胖风险至关重要.

科学领域:

临床医学临床医学
精神病学是一个精神病学.
代谢障碍代谢障碍代谢障碍

背景情况:

重度抑郁症 (MDD) 是一种普遍存在的慢性精神疾病.
长期的MDD治疗可能会改变内部因素,可能使肥胖症恶化.
不同年龄组的MDD患者的代谢异常尚未得到充分了解.

研究的目的:

在稳定治疗期间,在所有年龄段的MDD患者中确定与肥胖相关的因素.
分析MDD患者体质指数 (BMI) 和各种代谢指标之间的关系.

主要方法:

收集了来自3个年龄组的205名MDD患者的数据:青少年,成人和晚年抑郁症.
测量体重,身高,BMI和与肥胖相关的代谢指数.
进行统计分析,包括多重线性回归,以确定相关性.

主要成果:

在MDD患者中,肥胖风险随着年龄的增长而增加.
体重指数显示与年龄,总胆固醇,甘油三,LDL,AST,LDH,尿酸,ALT,HbA1c和hs-CRP的正相关;与HDL的负相关.
多重回归确定了年龄,AST,ALT,尿酸,HbA1c和hs-CRP作为增加BMI的显著预测因素.

结论:

年龄是MDD患者肥胖风险的一个重要因素.
特定的血液代谢指标与MDD中的BMI相关.
建议在MDD患者的临床决策和肥胖风险降低方面更加关注监测血液代谢指标的年龄.

关键词:

这就是为什么BMI是BMI.大型抑郁症主要是抑郁症.代谢指数代谢指数肥胖肥胖肥胖肥胖肥胖肥胖肥胖肥胖超重的人超重.

更多相关视频

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

相关概念视频

Depressive Disorders: Etiology

Depressive Disorders: Etiology

Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...

Depressive Disorders: MDD and Dysthymia

Depressive Disorders: MDD and Dysthymia

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...

Long-term Depression

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.

Obesity

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...